These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 2464793

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of oral fludarabine phosphate in previously untreated patients with chronic lymphocytic leukemia.
    Rossi JF, van Hoof A, de Boeck K, Johnson SA, Bron D, Foussard C, Lister TA, Berthou C, Kramer MH, Littlewood TJ, Marcus RE, Deconinck E, Montillo M, Guibon O, Tollerfield SM.
    J Clin Oncol; 2004 Apr 01; 22(7):1260-7. PubMed ID: 15051774
    [Abstract] [Full Text] [Related]

  • 6. [Fludarabine monophosphate in the treatment of patients with advanced stages of chronic B-cell lymphatic leukemia resistant to conventional chemotherapy].
    Papajík T, Faber E, Hubácek J, Slezák P, Raida L, Heczko M, Sulovská I, Jarosová M, Pikalová Z, Indrák K.
    Vnitr Lek; 1997 Jan 01; 43(1):25-8. PubMed ID: 9221561
    [Abstract] [Full Text] [Related]

  • 7. Fludarabine monophosphate as salvage for refractory chronic lymphocytic leukaemia.
    Pillay GS, Wood L, Jacobs P.
    S Afr Med J; 1996 Aug 01; 86(8):949-51. PubMed ID: 8823419
    [Abstract] [Full Text] [Related]

  • 8. Activity of fludarabine monophosphate in patients with advanced mycosis fungoides: a Southwest Oncology Group study.
    Von Hoff DD, Dahlberg S, Hartstock RJ, Eyre HJ.
    J Natl Cancer Inst; 1990 Aug 15; 82(16):1353-5. PubMed ID: 1696322
    [No Abstract] [Full Text] [Related]

  • 9. Fludarabine: a new agent with marked cytoreductive activity in untreated chronic lymphocytic leukemia.
    Keating MJ, Kantarjian H, O'Brien S, Koller C, Talpaz M, Schachner J, Childs CC, Freireich EJ, McCredie KB.
    J Clin Oncol; 1991 Jan 15; 9(1):44-9. PubMed ID: 1702145
    [Abstract] [Full Text] [Related]

  • 10. Phase II trial of fludarabine in patients with epithelial ovarian cancer.
    Kavanagh JJ, Stringer CA, Copeland LJ, Gershenson DM, Saul P.
    Cancer Treat Rep; 1986 Mar 15; 70(3):425-6. PubMed ID: 2420446
    [No Abstract] [Full Text] [Related]

  • 11. Evaluation of fludarabine phosphate in renal cell carcinoma: a Southwest Oncology Group Study.
    Balducci L, Blumenstein B, Von Hoff DD, Davis M, Hynes HE, Bukowski RM, Crawford ED.
    Cancer Treat Rep; 1987 May 15; 71(5):543-4. PubMed ID: 2436773
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Fludarabine phosphate in chronic lymphoproliferative diseases. The French Group on CLL.
    Binet JL.
    Nouv Rev Fr Hematol (1978); 1993 Feb 15; 35(1):5-7. PubMed ID: 7685518
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Treatment of advanced chronic lymphocytic leukemia by fludarabine. Results of a clinical phase-II study.
    Hiddemann W, Rottmann R, Wörmann B, Thiel A, Essink M, Ottensmeier C, Freund M, Büchner T, van de Loo J.
    Ann Hematol; 1991 Jul 15; 63(1):1-4. PubMed ID: 1715191
    [Abstract] [Full Text] [Related]

  • 18. A comprehensive phase I and II clinical investigation of fludarabine phosphate.
    Grever M, Leiby J, Kraut E, Metz E, Neidhart J, Balcerzak S, Malspeis L.
    Semin Oncol; 1990 Oct 15; 17(5 Suppl 8):39-48. PubMed ID: 1699282
    [Abstract] [Full Text] [Related]

  • 19. [Phase I clinical study of SH L573 (fludarabine phosphate) in patients with chronic lymphocytic leukemia and adult T-cell leukemia/lymphoma].
    Arima N, Mizoguchi H, Shirakawa S, Tomonaga M, Takatsuki K, Ohno R.
    Gan To Kagaku Ryoho; 1999 Apr 15; 26(5):619-29. PubMed ID: 10234292
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.